1. Home
  2. ASTL vs ZURA Comparison

ASTL vs ZURA Comparison

Compare ASTL & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

N/A

Current Price

$5.52

Market Cap

522.0M

Sector

Industrials

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$0.98

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTL
ZURA
Founded
1902
2022
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.0M
455.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ASTL
ZURA
Price
$5.52
$0.98
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$5.64
★ $19.00
AVG Volume (30 Days)
1.3M
★ 5.0M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$68.36
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$3.25
52 Week High
$5.90
$7.25

Technical Indicators

Market Signals
Indicator
ASTL
ZURA
Relative Strength Index (RSI) 68.44 23.43
Support Level $4.12 N/A
Resistance Level $5.90 $6.05
Average True Range (ATR) 0.36 0.47
MACD 0.08 -0.15
Stochastic Oscillator 98.31 0.43

Price Performance

Historical Comparison
ASTL
ZURA

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from United States. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: